ENTITY

Dyadic International (DYAI US)

15
Analysis
Health Care • United States
Dyadic International, Inc. is a global biotechnology company. The Company focuses on improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. Dyadic International focuses on drugs that will improve access and cost to patients as well as save lives.
more
Company Event • 12 Nov 2026 06:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 29 Sep 2026 22:30 • Latest

Lytham Partners Fall 2026 Investor Conference

Company Event • 16 Sep 2026 00:00

IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026

Company Event • 11 Sep 2026 20:00 • Upcoming
Add To Calendar

Registration filing

Company Event • 27 Aug 2026 03:00

Q3 Investor Summit Group Virtual Conference 2026

x